Clinical Trials Browser

Phase 2 × Recruiting × siltuximab × Clear all

NCT06470971 2026-01-20

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Phase 2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT05684692 2025-10-30

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Phase 2 Recruiting

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

NCT07106671 2025-08-06

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

Phase 2 Recruiting

Cytokine Release Syndrome, Neoplasms, Plasma Cell